Bifidobacterium breve B-3 exerts metabolic syndrome-suppressing effects in the liver of diet-induced obese mice: a DNA microarray analysis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Beneficial Microbes

• Publication date

  2013-05-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3920/BM2012.0019PMID 23666099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of fatty acids and polyphenols in inflammatory gene transcription and their impact on obesity, metabolic syndrome and diabetes.

  2012cited by this paper
• Activation of the Acute Inflammatory Response Alters Cytochrome P450 Expression and Eicosanoid Metabolism

  2011cited by this paper
• Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats

  2011cited by this paper
• Serum Amyloid A Facilitates the Binding of High-Density Lipoprotein From Mice Injected With Lipopolysaccharide to Vascular Proteoglycans

  2011cited by this paper
• Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial

  2010cited by this paper
• Antiobesity Effects of Bifidobacterium breve Strain B-3 Supplementation in a Mouse Model with High-Fat Diet-Induced Obesity

  2010cited by this paper
• Lactobacillus plantarum strain No. 14 reduces adipocyte size in mice fed high-fat diet

  2010cited by this paper
• PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid ω-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease

  2010cited by this paper
• Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

  2009cited by this paper
• Anti-obesity effects of conjugated linoleic acid, docosahexaenoic acid, and eicosapentaenoic acid.

  2008cited by this paper
• Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice

  2008cited by this paper
• A distribution free summarization method for Affymetrix GeneChip arrays.

  2007cited by this paper
• Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia

  2007cited by this paper
• Antiobesity effect of trans‐10,cis‐12‐conjugated linoleic acid‐producing Lactobacillus plantarum PL62 on diet‐induced obese mice

  2007cited by this paper
• Hepatic Cytochrome P450 Gene Regulation during Endotoxin-Induced Inflammation in Nuclear Receptor Knockout Mice

  2005cited by this paper
• The gut microbiota as an environmental factor that regulates fat storage.

  2004cited by this paper
• Role for ELOVL3 and Fatty Acid Chain Length in Development of Hair and Skin Function*

  2004cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• Identification and expression of mammalian long-chain PUFA elongation enzymes

  2002cited by this paper
• Role of a New Mammalian Gene Family in the Biosynthesis of Very Long Chain Fatty Acids and Sphingolipids

  2000cited by this paper
• Alpha-1-acid glycoprotein.

  2000cited by this paper
• Cloning, Expression, and Nutritional Regulation of the Mammalian Δ-6 Desaturase*

  1999cited by this paper

• Targeting the Gut Microbiota in Pediatric Obesity: A Paradigm Shift in Prevention and Treatment? A Comprehensive Review

  2025cites this paper
• Effects of Bifidobacterium longum BB536 and Bifidobacterium breve MCC1274 on Body Composition in Normal and Overweight Adults in Randomized Placebo-Controlled Study

  2024cites this paper
• Probiotics supplementation or probiotic-fortified products on sarcopenic indices in older adults: systematic review and meta-analysis from recent randomized controlled trials

  2024cites this paper
• The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives

  2023cites this paper
• Levilactobacillus brevis from carnivores can ameliorate hypercholesterolemia: In vitro and in vivo mechanistic evidence

  2022cites this paper
• Body Fat Reduction Effect of Bifidobacterium breve B-3: A Randomized, Double-Blind, Placebo Comparative Clinical Trial

  2022cites this paper
• Wangshi Baochi Pills Alleviate Alcoholic Liver Disease by Regulating the Gut Microbiota Composition in a Mouse Model

  2022cites this paper
• Bifidobacterium breve MCC1274 Supplementation Increased the Plasma Levels of Metabolites with Potential Anti-Oxidative Activity in APP Knock-In Mice

  2022cites this paper
• Supplementation with Bifidobacterium breve BR03 and B632 strains improved insulin sensitivity in children and adolescents with obesity in a cross-over, randomized double-blind placebo-controlled trial.

  2021cites this paper
• Dietary intake of bioactive ingredients impacts liver and adipose tissue transcriptomes in a porcine model of prepubertal early obesity

  2020cites this paper
• Effect of probiotics on obesity-related markers per enterotype: a double-blind, placebo-controlled, randomized clinical trial

  2020cites this paper
• The probiotic L. casei LC-XCAL™ improves metabolic health in a diet-induced obesity mouse model without altering the microbiome

  2020cites this paper
• Association between Gut Microbiota and Infant’s Temperament in the First Year of Life in a Chinese Birth Cohort

  2020cites this paper
• Bifidobacterium breve strain IDCC 4401 improves dyslipidemia in rat model

  2020cites this paper
• Effects of a high-fat-diet supplemented with probiotics and ω3-fatty acids on appetite regulatory neuropeptides and neurotransmitters in a pig model.

  2020cites this paper
• Variation in the Gut Microbiota of Common Marmosets: Differences with Colony of Origin and Integration

  2020cites this paper
• The activities of the ILSI Japan endowed chair, at the University of Tokyo, regarding functional food genomics.

  2020cites this paper
• 1 Towards Individualized Use of Probiotics and 2 Prebiotics for Metabolic Syndrome and Associated 3 Diseases Treatment : Does Pathophysiology-Based 4 Approach Work and Can Anticipated Evidence Be 5 Completed ? 6

  2018cites this paper
• Therapeutic Microbiology: The Role of Bifidobacterium breve as Food Supplement for the Prevention/Treatment of Paediatric Diseases

  2018cites this paper
• Effects of Bifidobacterium breve B-3 on body fat reductions in pre-obese adults: a randomized, double-blind, placebo-controlled trial

  2018cites this paper
• Effect of combined bifidobacteria supplementation and resistance training on cognitive function, body composition and bowel habits of healthy elderly subjects.

  2018cites this paper
• Probiotic strains and mechanistic insights for the treatment of type 2 diabetes

  2017cites this paper
• Comparative study of probiotic effects of Lactobacillus and Bifidobacteria strains on cholesterol levels, liver morphology and the gut microbiota in obese mice

  2017cites this paper
• Microbial Impact on Host Metabolism: Opportunities for Novel Treatments of Nutritional Disorders?

  2017cites this paper
• Prosteatotic and Protective Components in a Unique Model of Fatty Liver: Gut Microbiota and Suppressed Complement System

  2016cites this paper
• Gut Microbiota: A Contributing Factor to Obesity

  2016cites this paper
• Administration of a maple syrup extract to mitigate their hepatic inflammation induced by a high-fat diet: a transcriptome analysis

  2015cites this paper
• Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial

  2015cites this paper
• Novel opportunities for next-generation probiotics targeting metabolic syndrome.

  2015cites this paper
• Effect of Bifidobacterium breve B-3 on skin photoaging induced by chronic UV irradiation in mice.

  2015cites this paper
• Lactic Acid Bacteria in Health and Disease

  2014cites this paper
• Lactic Acid Bacteria

  2014cites this paper